Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CVTX - CV Therapeutics, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: mopgcw who wrote (277)	8/14/2006 1:51:21 PM
From: rkrw	Respond to of 411

Lange has been a really arrogant ceo and arrogance doesn't often pay. $400M in cv debt, yet about 1-year of cash left carrying forward the Q2 burn rate. CV is burning through money like water. I think he had to raise money now rather than risk ranexa continuing to ramp slowly or bad upcoming data. cv would be in a ntmd like position if those two things happened along with a lousy cash position. Not that 7.5M buys them all that much time, only one quarters worth. Hopefully he does have a plan :-)